Phosphorus dendrimers as carriers of siRNA-characterisation of dendriplexes

Molecules

Volumn 18, Issue 4, 2013, Pages 4451-4466

  Ferenc, Malgorzata ^a   Pedziwiatr Werbicka, Elzbieta ^a   Nowak, Katarzyna E ^a   Klajnert, Barbara ^a   Majoral, Jean Pierre ^b   Bryszewska, Maria ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b LCC LABORATOIRE DE CHIMIE DE COORDINATION   (France)

Author keywords

Chronic myeloid leukemia; Dendriplex; Gene therapy; Phosphorus dendrimers; SiRNA

Indexed keywords

BREAKPOINT CLUSTER REGION PROTEIN; DENDRIMER; ETHIDIUM; NANOPARTICLE; PHOSPHORUS; SMALL INTERFERING RNA;

ARTICLE; BIOPHYSICS; CHEMISTRY; CHRONIC MYELOID LEUKEMIA; CIRCULAR DICHROISM; GENE SILENCING; GENE THERAPY; GENE TRANSFER; GENETICS; HUMAN; METABOLISM; METHODOLOGY; PARTICLE SIZE;

BIOPHYSICS; CIRCULAR DICHROISM; DENDRIMERS; ETHIDIUM; GENE SILENCING; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; NANOPARTICLES; PARTICLE SIZE; PHOSPHORUS; PROTO-ONCOGENE PROTEINS C-BCR; RNA, SMALL INTERFERING;

EID: 84876782022     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18044451     Document Type: Article

References (40)

1. Verma, M.; Somia, N. Gene therapy - promises, problems and prospects. Nature 1997, 389, 239-242.
2. Huang, L.; Viroonchatapan, E. Introduction. In Non-viral Vector for Gene Therapy; Huang, L., Wagner, M., Eds.; Academic Press: New York, NY, USA, 1999; pp. 3-22.
3. Hannon, G.J. RNA interference. Nature 2002, 418, 244-251.
4. Elbashir, S.M.; Harborth, J.; Lendeckel, W.; Yalcin, A.; Weber, K.; Tuschl, T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411, 494-498.
5. Tomalia, D.A.; Baker, H.; Dewald, J.; Hall, M.; Kallos, G.; Martin, S.; Roeck, J.; Ryder, J.; Smith, P. A new class of polymers: Starburst-dendritic macromolecules. Polym. J. 1985, 17, 117-132.
6. Klajnert, B.; Bryszewska, M. Dendrimers: Properties and applications. Acta Biochim. Pol. 2001, 48, 199-208.
7. Galliot, C.; Larré, C.; Caminade, A.M.; Majoral, J.P. Regioselective stepwise growth of dendrimer units in the internal voids of a main dendrimer. Science 1997, 277, 1981-1984.
8. Merino, S.; Brauge, L.; Caminade, A.M.; Majoral, J.P.; Taton, D.; Gnanou, Y. Synthesis and characterization of linear, Hyperbranched, and dendrimer-like polymers constituted of the same repeating unit. Chemistry 2001, 7, 3095-3105.
9. Caminade, A.M.; Majoral, J.P. Water-soluble phosphorus-containing dendrimers. Prog. Polym. Sci. 2005, 30, 491-505.
10. Solassol, J.; Crozet, C.; Perrier, V.; Leclaire, J.; Béranger, F.; Caminade, A.M.; Meunier, B.; Dormont, D.; Majoral, J.P.; Lehmann, S. Cationic phosphorus-containing dendrimers reduce prion replication both in cell culture and in mice infected with scrapie. J. Gen. Virol. 2004, 85, 1791-1799.
11. Loup, C.; Zanta, M.A.; Caminade, A.M.; Majoral, J.P.; Meunier, B. Preparation of water-soluble cationic phosphorus-containing dendrimers as DNA transfecting agents. Chem. Eur. J. 1999, 5, 3644-3650.
12. Maksimenko, A.V.; Mandrouguine, V.; Gottikh, M.B.; Bertrand, J.R.; Majoral, J.P.; Malvy, C. Optimisation of dendrimer-mediated gene transfer by anionic oligomers. J. Gene. Med. 2003, 5, 61-71.
13. Ionov, M.; Wróbel, D.; Gardikis, K.; Hatziantoniou, S.; Demetzos, C.; Majoral, J.P.; Klajnert, B.; Bryszewska, M. Effect of phosphorus dendrimers on DMPC lipid membranes. Chem. Phys. Lipids 2011, 165, 408-413.
14. Wrobel, D.; Ionov, M.; Gardikis, K.; Demetzos, C.; Majoral, J.P.; Palecz, B.; Klajnert, B.; Bryszewska, M. Interactions of phosphorus-containing dendrimers with liposomes. Biochim. Biophys. Acta 2010, 1811, 221-226.
15. Griffe, L.; Poupot, M.; Marchand, P.; Maraval, A.; Turrin, C.O.; Rolland, O.; Métivier, P.; Bacquet, G.; Fournié, J.J.; Caminade, A.M.; et al. Multiplication of human natural killer cells by nanosized phosphonate-capped dendrimers. Angew. Chem. Int. Ed. Engl. 2007, 46, 2523-2526.
16. Poupot, M.; Griffe, L.; Marchand, P.; Maraval, A.; Rolland, O.; Martinet, L.; L'Faqihi-Olive, F.E.; Turrin, C.O.; Caminade, A.M.; Fournié, J.J.; et al. Design of phosphorylated dendritic architectures to promote human monocyte activation. FASEB J. 2006, 20, 2339-2351.
17. Hayder, M.; Poupot, M.; Baron, M.; Nigon, D.; Turrin, C.O.; Caminade, A.M.; Majoral, J.P.; Eisenberg, R.A.; Fournie, J.J.; Cantagrel, A.; et al. A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis. Sci. Transl. Med. 2011, 3, 81ra35.
18. Rolland, O.; Griffe, L.; Poupot, M.; Maraval, A.; Ouali, A.; Coppel, Y.; Fournié, J.J.; Bacquet, G.; Turrin, C.O.; Caminade, A.M.; et al. Tailored control and optimisation of the number of phosphonic acid termini on phosphorus-containing dendrimers for the ex vivo activation of human monocytes. Chemistry 2008, 14, 4836-4850.
19. Shcharbin, D.; Dzmitruk, V.; Shakhbazau, A.; Goncharova, N.; Seviaryn, I.; Kosmacheva, S.; Potapnev, M.; Pedziwiatr-Werbicka, E.; Bryszewska, M.; Talabaev, M.; et al. Fourth generation phosphorus-containing dendrimers: Prospective drug and gene delivery carrier. Pharmaceutics 2011, 3, 458-473.
20. Eftink, M.R. Fluorescence quenching reactions: Probing biological macromolecular structures. In Biophysical and Biochemical Aspects of Fluorescence Spectroscopy; Dewey, T.G., Ed.; Plenum: New York, NY, USA, 1991; pp. 1-41.
21. Akhtar, S.; Hughes, M.D.; Khan, A.; Bibby, M.; Hussain, M.; Nawaz, Q.; Double, J.; Sayyed, P. The delivery of antisense therapeutics. Adv. Drug Deliver. Rev. 2000, 44, 3-21.
22. Akhtar, S.; Juliano, R.L. Cellular and intracellular fate of antisense oligonucleotides. Trends Cell Biol. 1992, 2, 139-144.
23. Hussain, M.; Shchepinov, M.; Sohail, M.; Benter, I.F.; Hollins, A.J.; Southern, E.M.; Akhtar, S. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides. J. Control. Release 2004, 99, 139-155.
24. Bumcrot, D.; Manoharan. M.; Koteliansky, V.; Sah, D.W. RNAi therapeutics: A potential new class of pharmaceutical drugs. Nat. Chem. Biol. 2006, 2, 711-719.
25. Kathlen, F.; Zon, G.; Rati, A.; Zhou, Q.; Yo, W. Targeting Nanoimmunoliposome Complex for Short Interfering RNA Delivery. Hum. Gene Ther. 2006, 17, 117-124.
26. Lam, J.K.W.; Liang, W.; Chan, H.K. Pulmonary delivery of therapeutic siRNA. Adv. Drug Deliver. Rev. 2011, 64, 1-15.
27. Juliano, R.; Alam, M.R.; Dixit, V.; Kang, H. Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Res. 2008, 36, 4158-4171.
28. Aigner, A. Nonviral in vivo delivery of therapeutic small interfering RNAs. Curr. Opin. Mol. Ther. 2007, 9, 345-352.
29. D'Emanuele, A.; Attwood, D. Dendrimer-drug interactions. Adv. Drug Deliver. Rev. 2005, 57, 2147-2162.
30. Quillardet, P.; Hofnung, M. Ethidium bromide and safety - Readers suggest alternative solutions. Trends Genet. 1988, 4, 89-93.
31. Hashizume, H.; Imahori, M. Circular dichroism and the conformation of natural and synthetic polynucleotides. J. Biochem. 1967, 61, 738-749.
32. Tritton, T.R.; Crothers, D.M. Physical characterization of a ribosomal nucleoprotein complex. Biochemistry 1976, 15, 4377-4385.
33. Chiu, Y.L.; Rana, T.M. RNAi in human cells: Basic structural and functional features of small interfering RNA. Mol. Cell 2002, 10, 549-561.
34. Plank, C.; Mechtler, K.; Szoka, F.C.; Wagner, E. Activation of the complement system by synthetic DNA complexes: A potential barrier to intravenous gene delivery. Hum. Gene Ther. 1996, 7, 1437-1446.
35. Pouton, C.W.; Seymour, L.W. Key issues in non-viral gene delivery. Adv. Drug Deliver. Rev. 1998, 34, 3-19.
36. Jensen, L.B.; Pavan, G.M.; Kasimova, M.R.; Rutherford, S.; Danani, A.; Nielsen, H.M.; Foged, C. Elucidating the molecular mechanism of PAMAM-siRNA dendriplex self-assembly: Effect of dendrimer charge density. Int. J. Pharm. 2011, 416, 410-418.
37. Fang, M.; Cheng, Y.; Zhang, J.; Wu, Q.; Hu, J.; Zhao, L.; Xu, T. New insights into interactions between dendrimers and surfactants. 4. Fast-exchange/slow-exchange transitions in the structure of dendrimer-surfactant aggregates. J. Phys. Chem. B 2010, 114, 6048-6055.
38. Oh, Y.K.; Park, T.G. siRNA delivery systems for cancer treatment. Adv. Drug Deliver. Rev. 2009, 61, 850-862.
39. Tsai, C.C.; Jain, S.C.; Sobel, H.M. Visualization of drug-nucleic acid interactions at atomic resolution. I. Structure of an ethidium/dinucleoside monophosphate crystalline complex, ethidium:5-iodouridylyl (3'-5') adenosine. J. Mol. Biol. 1977, 114, 301-315.
40. Peng, Y.; Zhang, Q.; Nagasawa, H.; Okayasu, R.; Liber, H.; Bedford, J. Silencing expression of the catalytic subunit of DNA-dependent protein kinase by small interfering RNA sensitizes human cells for radiation-induced chromosome damage, cell killing, and mutation. Cancer Res. 2002, 62, 6400-6404.